Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
about
Endometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical DilemmasEpigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cellsSingle nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progressionBD-Func: a streamlined algorithm for predicting activation and inhibition of pathways.Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.Oncogenic Wnt/β-catenin signalling pathways in the cancer-resistant epididymis have implications for cancer research.Cell and matrix response of temporomandibular cartilage to mechanical loading.Serum biomarker analysis in patients with recurrent spontaneous abortion.Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway.Endometrial Carcinoma: Specific Targeted Pathways.p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance.Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials.Dickkopf Homolog 3 (DKK3): a candidate for detection and treatment of cancers?Dickkopf-3 Causes Neuroprotection by Inducing Vascular Endothelial Growth Factor
P2860
Q28074769-F865B161-0B71-4385-AF3E-779F8E100648Q34154767-4F95C388-8639-4030-B0D4-465F1F813F2FQ36589284-3A956457-66C9-4FC5-8A4B-BD940475124CQ37178599-FD7EBB06-9EFF-4792-B057-8F3B409E05D2Q37334480-83E8439E-7A54-4891-AE32-F7477C167DE7Q38060099-6A7C93E2-8CDB-49EC-A297-B38CCCA8C43DQ38541509-12731524-1754-441B-B8E9-5990EC4B0151Q38693339-9B0577FB-3A1E-4666-89DA-BB751929FE71Q38814061-186AD3A1-F4B9-49D3-8B3B-8AD1A5478B15Q39026766-0159F512-0662-4F45-9344-541DC2733867Q42362115-AA73D637-B20C-4A47-BE71-7BDB7912C49AQ45848384-900EAB75-BA4B-4BC3-99C4-34FB47A36961Q47329728-75CDA46E-C329-4B7E-BAE4-89A27BC1B61AQ58750104-337CCC90-67D5-4E1A-8A7C-5F6536D1E4DC
P2860
Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Expression of the Wnt antagoni ...... nvasion in endometrial cancer.
@en
type
label
Expression of the Wnt antagoni ...... nvasion in endometrial cancer.
@en
prefLabel
Expression of the Wnt antagoni ...... nvasion in endometrial cancer.
@en
P2093
P2860
P1433
P1476
Expression of the Wnt antagoni ...... nvasion in endometrial cancer.
@en
P2093
Bradley J Monk
Danielle D Jandial
Kestutis Planutis
Micaela E Martinez
Ramez N Eskander
Randall F Holcombe
Thanh H Dellinger
Xiaolin Zi
P2860
P304
P356
10.1016/J.YGYNO.2012.04.026
P407
P577
2012-04-30T00:00:00Z